These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19520186)

  • 1. Effects of a PPAR-gamma agonist, on growth factor and insulin stimulated endothelial cells.
    Desouza CV; Gerety M; Hamel FG
    Vascul Pharmacol; 2009; 51(2-3):162-8. PubMed ID: 19520186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of a PPAR-gamma agonist, pioglitazone, on neointimal hyperplasia and endothelial regrowth in insulin resistant rats.
    Desouza CV; Gerety M; Hamel FG
    Vascul Pharmacol; 2007 Mar; 46(3):188-94. PubMed ID: 17141574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
    Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S
    Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPAR gamma ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis.
    Aljada A; O'Connor L; Fu YY; Mousa SA
    Angiogenesis; 2008; 11(4):361-7. PubMed ID: 18810647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells.
    Tamura K; Hashimoto K; Suzuki K; Yoshie M; Kutsukake M; Sakurai T
    Eur J Pharmacol; 2009 May; 610(1-3):61-7. PubMed ID: 19374835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature.
    Duan SZ; Usher MG; Mortensen RM
    Circ Res; 2008 Feb; 102(3):283-94. PubMed ID: 18276926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-alpha and interferon-gamma inflammatory effects in human endothelial cells.
    Lombardi A; Cantini G; Piscitelli E; Gelmini S; Francalanci M; Mello T; Ceni E; Varano G; Forti G; Rotondi M; Galli A; Serio M; Luconi M
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):718-24. PubMed ID: 18239149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosiglitazone antagonizes vascular endothelial growth factor signaling and nuclear factor of activated T cells activation in cardiac valve endothelium.
    Sander TL; Noll L; Klinkner DB; Weihrauch D; He BJ; Kaul S; Zangwill SD; Tweddell JS; Pritchard KA; Oldham KT
    Endothelium; 2006; 13(3):181-90. PubMed ID: 16840174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of peroxisome proliferator-activated receptor-γ agonists on the generation of microparticles by monocytes/macrophages.
    Neri T; Cordazzo C; Carmazzi Y; Petrini S; Balìa C; Stefanelli F; Amoruso A; Brunelleschi S; Breschi MC; Pedrinelli R; Paggiaro P; Celi A
    Cardiovasc Res; 2012 Jun; 94(3):537-44. PubMed ID: 22425902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of beta-escin sodium on endothelial cells proliferation, migration and apoptosis.
    Wang XH; Xu B; Liu JT; Cui JR
    Vascul Pharmacol; 2008; 49(4-6):158-65. PubMed ID: 18718875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor-gamma activation with pioglitazone improves endothelium-dependent dilation in nondiabetic patients with major cardiovascular risk factors.
    Campia U; Matuskey LA; Panza JA
    Circulation; 2006 Feb; 113(6):867-75. PubMed ID: 16461819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor alpha and gamma ligands inhibit the growth of human ovarian cancer.
    Shigeto T; Yokoyama Y; Xin B; Mizunuma H
    Oncol Rep; 2007 Oct; 18(4):833-40. PubMed ID: 17786343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPAR-gamma ligands up-regulate basic fibroblast growth factor-induced VEGF release through amplifying SAPK/JNK activation in osteoblasts.
    Yasuda E; Tokuda H; Ishisaki A; Hirade K; Kanno Y; Hanai Y; Nakamura N; Noda T; Katagiri Y; Kozawa O
    Biochem Biophys Res Commun; 2005 Mar; 328(1):137-43. PubMed ID: 15670761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of testosterone on extracellular signal-regulated kinase 1/2 phosphorylation in human umbilical vein endothelial cells].
    Jin H; Zhang XY; Peng G; Qiu WB; Wang DM; Li YG
    Zhonghua Nan Ke Xue; 2007 Sep; 13(9):777-9. PubMed ID: 17929550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective activation of peroxisome proliferator-activated receptor (PPAR)alpha and PPAR gamma induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism.
    Biscetti F; Gaetani E; Flex A; Aprahamian T; Hopkins T; Straface G; Pecorini G; Stigliano E; Smith RC; Angelini F; Castellot JJ; Pola R
    Diabetes; 2008 May; 57(5):1394-404. PubMed ID: 18268046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone inhibits homocysteine-induced migration of vascular smooth muscle cells through a peroxisome proliferator-activated receptor gamma-independent mechanism.
    Li L; Gao PJ; Xi R; Wu CF; Zhu DL; Yan J; Lu GP
    Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1471-6. PubMed ID: 18759864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells.
    Dai J; Peng L; Fan K; Wang H; Wei R; Ji G; Cai J; Lu B; Li B; Zhang D; Kang Y; Tan M; Qian W; Guo Y
    Oncogene; 2009 Sep; 28(38):3412-22. PubMed ID: 19597469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pioglitazone activates aortic telomerase and prevents stress-induced endothelial apoptosis.
    Werner C; Gensch C; Pöss J; Haendeler J; Böhm M; Laufs U
    Atherosclerosis; 2011 May; 216(1):23-34. PubMed ID: 21396644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor gamma (PPAR) agonism reduces the insulin-stimulated increase in circulating interleukin-6 in GH replaced GH-deficient adults.
    Krag MB; Rasmussen LM; Hansen TK; Frystyk J; Flyvbjerg A; Møller N; Jørgensen JO
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):363-8. PubMed ID: 19067726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial progenitor cells may inhibit apoptosis of pulmonary microvascular endothelial cells: new insights into cell therapy for pulmonary arterial hypertension.
    Xia L; Fu GS; Yang JX; Zhang FR; Wang XX
    Cytotherapy; 2009; 11(4):492-502. PubMed ID: 19526390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.